<DOC>
	<DOCNO>NCT00887744</DOCNO>
	<brief_summary>The primary purpose study measure change severity symptom ability function every day activity patient suffer degenerative lumbar spinal stenosis treatment Aperius速 device .</brief_summary>
	<brief_title>Intermittent Neurogenic Claudication Treatment With APERIUS速</brief_title>
	<detailed_description>The Intermittent Neurogenic Claudication Treatment Aperius速 ( INCA ) trial design multicenter single arm post-marketing study evaluate safety effectiveness Aperius速 patient degenerative lumbar stenosis symptomatic neurogenic intermittent claudication . One hundred fifty six patient history Degenerative lumbar spinal stenosis ( Lumbar level L1 L5 ) one maximum 2 level symptom neurogenic intermittent claudication without back pain include . All patient follow 12 month visit 48 hour , 7 day , 6 week , 6 12 month . Primary effectiveness endpoint assess mean percentage change baseline Zurich Claudication Questionnaire Symptom Severity 6 week . Other effectiveness outcome percentage change Zurich Claudication Questionnaire score ( ZCQ ) , Quality laife Questionnaire score ( call EuroQuol 5D EQ-5D ) , Visual Analogue Scale ( VAS ) pain score ( back , leg buttock groin pain ) , pain medication change walk distance baseline follow-up . Procedure device relate Serious Adverse Events assess throughout complete 12 month follow-up period .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Intermittent Claudication</mesh_term>
	<mesh_term>Spinal Stenosis</mesh_term>
	<criteria>History Degenerative Lumbar Spinal Stenosis ( Lumbar spine level L1 L5 ) , confirm Magnetic Resonance Imaging ( MRI ) one maximal two level , symptom intermittent neurogenic claudication . Leg / Buttock / Groin pain , without back pain , relieve flexion . If back pain also present , must partially relieve flexed . Able sit 50 minute without pain . Able walk distance 20 meter without pain . Patient state availability willing perform follow examination . Patient sign informed consent form . Adults ( minimum 21 year age ) . Previous lumbar surgery . Unremitting pain ( leg/buttock/groin/back ) spinal position . Axial back pain without leg/buttock/groin pain . Significant lumbar instability affect level : spondylolisthesis great grade 1 scale 14 . Objective motor deficit . Significant peripheral neuropathy nerve conduction velocity test ( peroneal sural nerve ) accord investigator . Cauda equina syndrome , defined neural compression cause neurogenic bowel ( rectal incontinence ) bladder dysfunction ( retention incontinence ) . Spinal Stenosis clinical symptom one level outside L1L5 lumbar region . Severe symptomatic Spinal Stenosis require immediate surgical decompression , accord investigator lumbar spinal stenosis 2 level . Lumbar Spinal Stenosis , cause tumor , metastasis Paget 's disease . Vascular claudication severe peripheral vascular disease . ( Diminished dorsalis pedis tibial pulse ) limit walk . History primary secondary osteoporosis define DXA scan ( =dual energy xray absorptiometry ) hip show Tscore ( =the number standard deviation mean patient 's age , sex ethnicity ) 2.5 standard deviation mean presence one fragility fracture . Active systemic infection local infection level treat . Major Depression accord Diagnostic Statistical Manual Mental Disorders ( DSM ) IV criterion . Dementia and/or inability give inform consent . Unable complete study . Pregnancy breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Degenerative Lumbar Spinal Stenosis</keyword>
	<keyword>Neurogenic Intermittent Claudication</keyword>
	<keyword>Interpinous Device</keyword>
	<keyword>Percutaneous</keyword>
</DOC>